CD19-Synthetic T Cell Antigen Receptor(STAR)-T in B-cell Malignancies Patients

NCT03953599 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

B Cell Malignancy

Interventions

BIOLOGICAL: CD19-STAR-T cells

Sponsor

Hebei Yanda Ludaopei Hospital

Collaborators

[object Object]